IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., a developer of a novel implantable Sacral Neuromodulation System (SNM) for the treatment of urinary and fecal dysfunction, announced today that it has been selected to present its technology advancements during the Innovations in Neuromodulation session at the International Neuromodulation Society congress on Saturday, June 6, 2015 at the Fairmont Queen Elizabeth Hotel in Montreal, Quebec, Canada.
Help employers find you! Check out all the jobs and post your resume.
